Microscopic-observation drug-susceptibility assay for the diagnosis of TB

被引:339
作者
Moore, David A. J.
Evans, Carlton A. W.
Gilman, Robert H.
Caviedes, Luz
Coronel, Jorge
Vivar, Aldo
Sanchez, Eduardo
Pinedo, Yvette
Saravia, Juan Carlos
Salazar, Cayo
Oberhelman, Richard
Hollm-Delgado, Maria-Graciela
LaChira, Doris
Escombe, A. Roderick
Friedland, Jon S.
机构
[1] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis & Immun, London W12 0NN, England
[2] Univ London Imperial Coll Sci Technol & Med, Fac Med, Wellcome Ctr Clin Trop Med, London W12 0NN, England
[3] Asociac Benefica PRISMA, Lima, Peru
[4] Univ Peruana Cayetano Heredia, Lab Invest Enfermedades Infecciosas, Lima, Peru
[5] Hosp Nacl Gen Arzobispo Loaya, Lima, Peru
[6] Hosp Nacl Hipolito Unanue, Lima, Peru
[7] Minist Salud, Direcc Salud Lima Norte 3, Lima, Peru
[8] Minist Salud, Direcc Salud Lima Este 4, Lima, Peru
[9] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA
[10] Tulane Sch Publ Hlth & Trop Med, New Orleans, LA USA
关键词
D O I
10.1056/NEJMoa055524
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND New diagnostic tools are urgently needed to interrupt the transmission of tuberculosis and multidrug-resistant tuberculosis. Rapid, sensitive detection of tuberculosis and multidrug-resistant tuberculosis in sputum has been demonstrated in proof-of-principle studies of the microscopic-observation drug-susceptibility (MODS) assay, in which broth cultures are examined microscopically to detect characteristic growth. METHODS In an operational setting in Peru, we investigated the performance of the MODS assay for culture and drug-susceptibility testing in three target groups: unselected patients with suspected tuberculosis, prescreened patients at high risk for tuberculosis or multidrug-resistant tuberculosis, and unselected hospitalized patients infected with the human immunodeficiency virus. We compared the MODS assay head-to-head with two reference methods: automated mycobacterial culture and culture on Lowenstein-Jensen medium with the proportion method. RESULTS Of 3760 sputum samples, 401 (10.7%) yielded cultures positive for Mycobacterium tuberculosis. Sensitivity of detection was 97.8% for MODS culture, 89.0% for automated mycobacterial culture, and 84.0% for Lowenstein-Jensen culture (P<0.001); the median time to culture positivity was 7 days, 13 days, and 26 days, respectively (P<0.001), and the median time to the results of susceptibility tests was 7 days, 22 days, and 68 days, respectively. The incremental benefit of a second MODS culture was minimal, particularly in patients at high risk for tuberculosis or multidrug-resistant tuberculosis. Agreement between MODS and the reference standard for susceptibility was 100% for rifampin, 97% for isoniazid, 99% for rifampin and isoniazid (combined results for multidrug resistance), 95% for ethambutol, and 92% for streptomycin (kappa values, 1.0, 0.89, 0.93, 0.71, and 0.72, respectively). CONCLUSIONS A single MODS culture of a sputum sample offers more rapid and sensitive detection of tuberculosis and multidrug-resistant tuberculosis than the existing gold-standard methods used.
引用
收藏
页码:1539 / 1550
页数:12
相关论文
共 41 条
[1]   Evaluation of indirect susceptibility testing of Mycobacterium tuberculosis to the first- and second-line, and alternative drugs by the newer MB/BacT system [J].
Barreto, AMW ;
Araújo, JBM ;
Medeiros, RFD ;
Caldas, PCD .
MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2003, 98 (06) :827-830
[2]   BIASES IN THE ASSESSMENT OF DIAGNOSTIC-TESTS [J].
BEGG, CB .
STATISTICS IN MEDICINE, 1987, 6 (04) :411-423
[3]   Multicenter evaluation of the MB/BACT system for susceptibility testing of Mycobacterium tuberculosis [J].
Bemer, P ;
Bodmer, T ;
Munzinger, J ;
Perrin, M ;
Vincent, W ;
Drugeon, H .
JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (03) :1030-1034
[4]   Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD initiative [J].
Bossuyt, PM ;
Reitsma, JB ;
Bruns, DE ;
Gatsonis, CA ;
Glasziou, PP ;
Irwig, LM ;
Lijmer, JG ;
Moher, D ;
Rennie, D ;
de Vet, HCW .
CLINICAL CHEMISTRY, 2003, 49 (01) :1-6
[5]   Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD initiative [J].
Bossuyt, PM ;
Reitsma, JB ;
Bruns, DE ;
Gatsonis, CA ;
Glasziou, PP ;
Irwig, LM ;
Lijmer, JG ;
Moher, D ;
Rennie, D ;
de Vet, HCW .
ANNALS OF INTERNAL MEDICINE, 2003, 138 (01) :40-44
[6]   Reliability of the MB/BacT system for testing susceptibility of Mycobacterium tuberculosis complex isolates to antituberculous drugs [J].
Brunello, F ;
Fontana, R .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (02) :872-873
[7]   Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures [J].
Caviedes, L ;
Lee, TS ;
Gilman, RH ;
Sheen, P ;
Spellman, E ;
Lee, EH ;
Berg, DE ;
Montenegro-James, S .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (03) :1203-1208
[8]   Clinical evaluation of a rapid immunochromatographic assay based on the 38 kDa antigen of Mycobacterium tuberculosis on patients with pulmonary tuberculosis in China [J].
Cole, RA ;
Lu, HM ;
Shi, YZ ;
Wang, J ;
DeHua, T ;
Zhou, AT .
TUBERCLE AND LUNG DISEASE, 1996, 77 (04) :363-368
[9]   Microplate Alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium [J].
Collins, LA ;
Franzblau, SG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (05) :1004-1009
[10]   Multiprimer PCR system for differential identification of mycobacteria in clinical samples [J].
DelPortillo, P ;
Thomas, MC ;
Martinez, E ;
Maranon, C ;
Valladares, B ;
Patarroyo, ME ;
Lopez, MC .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (02) :324-328